CMX-2043

N/A

Report date: 2023/08/31 13:51:08
NME

Base Information

Drug NameCMX-2043
Drug Alias NameCMX-2043LIP-EAR-LIP-EA-OH
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 modulators
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsNon-ST Elevated Myocardial InfarctionCoronary Artery DiseaseAngina, Unstable +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIschemix Llc
China Registration ClassN/A

Develop Information

Active CompaniesAltasciences Company Inc
Inactive CompaniesIschemix Llc
Active IndicationsBrain Injuries, Traumatic
Inactive IndicationsNon-ST Elevated Myocardial InfarctionCoronary Artery DiseaseAngina, Unstable +[4] 

Other Information

ATC CodeN/A
Related LinksN/A